🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07585838
Enrolling by invitation Not applicable

Hope-Focused Motivational Interviewing in Cancer Patients

NCT07585838 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-15
Last updated
2026-05-14

Condition(s) studied

Motivational InterventionCancerHopeSelf-CompassionSelf-Efficacy

Investigational drug(s) / intervention(s)

Hope-Focused Motivational Interviewing

Hope-Focused Motivational Interviewing: Participants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly. Each session will last approximately 30-40 minutes. The program includes the following components: (1) exploration of hope and goal setting, (2) enhancement of self-efficacy, (3) development of self-compassion, and (4) coping with barriers and creating a sustainable coping plan. Assessments will be conducted at baseline (pre-test), post-intervention, and at 1-month follow-up.

Study summary

This study aims to examine the effects of hope-focused motivational interviewing on levels of hope, self-efficacy, and self-compassion in patients with cancer receiving radiotherapy, using a randomized controlled design.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being 18 years of age or older * Having a diagnosis of Stage I-III cancer according to the TNM staging system Receiving radiotherapy at the study center (including adjuvant, neoadjuvant, or definitive RT) * Being in the first week of the radiotherapy process * Being able to read and understand Turkish and communicate at a level sufficient to participate in interviews * Agreeing to attend the intervention sessions at scheduled times and providing written informed consent Exclusion Criteria: * Presence of metastatic disease (Stage IV) or recurrent cancer * Receiving concurrent chemotherapy during the radiotherapy process * Presence of severe psychiatric conditions that may interfere with participation or the safe implementation of the intervention (e.g., psychotic disorders, bipolar disorder in the manic phase, or severe major depression) * Presence of moderate to severe cognitive impairment/dementia, significant attention or concentration problems, or neurological conditions that may compromise the reliability of responses * Severe hearing or speech impairments or communication difficulties that would prevent participation in interviews or completion of questionnaires (if appropriate support cannot be provided) * Participation in another structured psychosocial intervention program (e.g., hope-based, psychoeducational, or psychotherapeutic programs) during the study period

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bartın University Bartın Bartın

More Saglik Bilimleri Universitesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07585838 on ClinicalTrials.gov ↗ ← All trials in Turkey